Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma
Authors
Keywords
-
Journal
ANNALS OF CLINICAL BIOCHEMISTRY
Volume 55, Issue 4, Pages 478-484
Publisher
SAGE Publications
Online
2018-06-19
DOI
10.1177/0004563217741908
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Upregulation of microRNA-574-3p in a human gastric cancer cell line AGS by TGF-β1
- (2017) Renwen Zhang et al. GENE
- Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma
- (2017) Hao-Tu Zhu et al. LIVER INTERNATIONAL
- miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway
- (2016) Haidong Xu et al. Oncology Letters
- MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma
- (2016) Jie Xu et al. Advances in Clinical and Experimental Medicine
- Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D
- (2016) Lucy Baldeón Rojas et al. Diabetology & Metabolic Syndrome
- Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer
- (2015) Preethi Krishnan et al. BMC GENOMICS
- Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan
- (2015) Masatoshi Kudo Liver Cancer
- Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing
- (2014) H.-Y. Wang et al. CLINICAL CHEMISTRY
- miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
- (2013) Rounak Nassirpour et al. PLoS One
- microRNA Involvement in Hepatocellular Carcinoma
- (2012) Massimo Negrini et al. Anti-Cancer Agents in Medicinal Chemistry
- MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
- (2012) Silvia Giordano et al. HEPATOLOGY
- Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma
- (2011) Kevin Z. Qu et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma
- (2010) L.-M. Li et al. CANCER RESEARCH
- Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
- (2010) Jian Xu et al. MOLECULAR CARCINOGENESIS
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
- (2009) H. Su et al. CANCER RESEARCH
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
- (2008) Zhiyu Zhang et al. LABORATORY INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now